Axsome Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options.
2024/9/17 4:55:34
(AXSM:NASDAQ)
Streetwise Reports Articles